Cornwall & Isles of Scilly Community Prescribing and Dispensing News: 2019

 

Month

Topics

No. 302 December 2019
Pdf1

  • MHRA Drug Safety Update (Nov/Dec 19)
  • NICE Guidance 
    - NG 143 (Nov 19): Fever in under 5s: assessment and initial management
    - NG 144 (Nov 19): Cannabis-based medicinal products
    - NG 145 (Nov 19): Thyroid disease: assessment and management
    - TA 610 (Nov 19): Pentosan polysulfate sodium for treating bladder pain syndrome
    - TA 614 (Dec 19): Cannabidiol with clobazam for treating seizures associated with Dravet syndrome
    - TA 615 (Dec 19): Cannabidiol with clobazam for treating seizures associated with Lennox–Gastaut syndrome
    - NG (Dec 19): Menopause: diagnosis and management guideline
    - NG 148 (Dec 19): Acute kidney injury: prevention, detection and management guideline
  • Shared decision making
  • Cognitive psychology - Generalism and satisficers
  • Pharma promotion
  • Prescribing principles

No. 301 October 2019
 Pdf1

  • MHRA Drug Safety Update (Sep/Oct 19)
  • NICE Guidance 
    - NG 87 (Sep 19): Attention deficit hyperactivity disorder
    - NG 138 (Sep 19): Pneumonia (community-acquired)
    - TA 607 (Oct 19): Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease
    - CG 184 (Oct 19): Gastro-oesophageal reflux disease and dyspepsia in adults
  • Bisphosphonates for treating osteoporosis - Patient decision aid
  • UTI diagnosis
  • Antidepressants for major depressive disorder
  • Patient safety

No. 300 August 2019
Pdf1

  • MHRA Drug Safety Update (Aug 19)
  • CAPC Technical Working Group
    - Latanoprost and timolol preservative free eye drops (Fixapost)
    - Dorzolamide and timolol eye drops (Cosopt iMulti)
  • NICE Guidance 
    - CG 30 (Jul 19): Long-acting reversible contraception
    - NG 136 (Aug 19): Hypertension in adults: diagnosis and management
    - TA 597 (Aug 19): Dapagliflozin with insulin for treating type 1 diabetes
  • Consider shorter courses of antibiotics
  • How to communicate evidence to patients
  • Metformin and sulphonylurea
  • A blog on the future of shared decision making
  • Shared care guidelines

No. 299 July 2019
Pdf1

  • MHRA Drug Safety Update (June/July 2019)
  • Unlicensed oral liquids in paediatrics
  • NICE Guidance 
    - TA 583 (Jun 19): Ertugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor for treating type 2 diabetes
    - NG 133 (Jun 19): Hypertension in pregnancy
    - NG 134 (Jun 19): Depression in children and young people
  • Patient engagement
  • What is a biosimilar medicine
  • Cognitive biases
  • Patient safety
No. 298 May 2019
Pdf1
  • MHRA Drug Safety Update (May 2019)
  • CAPC Technical Working Group
    - Dymista nasal spray
  • NICE Guidance 
    - NG 127 (May 19): Suspected neurological conditions: recognition and referral
    - NG 129 (May 19): Crohn’s disease: management
    - NG 130 (May 19): Ulcerative colitis: management
    - NG 131 (May 19): Prostate cancer: diagnosis and management
  • Quality Improvement Guide
  • Cognition
  • Reforming disease definitions
  • Top tips: Dependence forming medications
  • Antidepressants
  • Community pharmacy guide for GPs & practice staff

No. 297 April 2019
Pdf1

  • MHRA Drug Safety Update (Apr 2019)
  • NICE Guidance 
    - NICE TA 572 (Mar 19): Ertugliflozin as monotherapy or with metformin for treating type 2 diabetes
    - NG80 - Asthma: diagnosis, monitoring and chronic asthma management - Patient decision aid
  • Clinical epidemiology resources
  • Omega 3 fatty acid
  • Valproate PPP
  • The case for being a medical conservative
  • If you don't read the book, then please read the blog ....
  • Reforming disease definitions
  • Top 20 most valuable pills?

No. 296 March 2019 Pdf1

  • MHRA Drug Safety Update (Feb / Mar 2019)
  • CAPC Technical Working Group
    - Hydrocortisone granules in capsules (Alkindi)
    Semaglutide (Ozempic)
  • Overdiagnosis blog
  • Multimorbidity
  • The medical reformation
  • NICE Guidance
    - CG 103 (Mar 19): Delirium: prevention, diagnosis and management
    - NG 120 (Feb 19): Cough (acute): antimicrobial prescribing
  • Standardised strengths of inlicensed liquid medicines

No. 295 January 2019 Pdf1

  • MHRA Drug Safety Update (Dec 2018)
  • NICE Guidance - NICE NG 115 (Dec 18): Chronic obstructive pulmonary disease in over 16s: diagnosis and management
  • NICE Guidance - NICE NG 114 (Dec 18): Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing
  • Journey of a NICE Guideline - Ever wondered how they are produced?
  • Inhaler technique
  • Rethinking medicine
  • Specialist Pharmacy Service - A great resource!